Diagnostic yield and clinical impact of chromosomal microarray analysis in autism spectrum disorder

BACKGROUND Autism spectrum disorder (ASD) is characterized by high heritability estimates and recurrence rates; its genetic underpinnings are very heterogeneous and include variable combinations of common and rare variants. Array-comparative genomic hybridization (aCGH) offers significant sensitivity for the identification of copy number variants (CNVs), which can act as susceptibility or causal factors for ASD. METHODS The aim of this study was to evaluate both diagnostic yield and clinical impact of aCGH in 329 ASD patients of Italian descent. RESULTS Pathogenic/likely pathogenic CNVs were identified in 50/329 (15.2%) patients, whereas 89/329 (27.1%) carry variants of uncertain significance. The 10 most enriched gene sets identified by Gene Ontology Enrichment Analysis are primarily involved in neuronal function and synaptic connectivity. In 13/50 (26.0%) patients with pathogenic/likely pathogenic CNVs, the outcome of array-CGH led to the request of 25 additional medical exams which would not have otherwise been prescribed, mainly including brain MRI, EEG, EKG, and/or cardiac ultrasound. A positive outcome was obtained in 12/25 (48.0%) of these additional tests. CONCLUSIONS This study confirms the satisfactory diagnostic yield of aCGH, underscoring its potential for better, more in-depth care of children with autism when genetic results are analyzed also with a focus on patient management.

[1]  M. Butler,et al.  Actionable Genomics in Clinical Practice: Paradigmatic Case Reports of Clinical and Therapeutic Strategies Based upon Genetic Testing , 2022, Genes.

[2]  C. Arango,et al.  The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present , 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  M. Butler,et al.  Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD) , 2020, International journal of molecular sciences.

[4]  S. Scherer,et al.  FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family , 2020, Molecular genetics & genomic medicine.

[5]  S. South,et al.  Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) , 2019, Genetics in Medicine.

[6]  Stefan N Hansen,et al.  Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort. , 2019, JAMA psychiatry.

[7]  Yuan Zhou,et al.  An integrated transcriptomic analysis of autism spectrum disorder , 2019, Scientific Reports.

[8]  Zhiyu Peng,et al.  AutoPVS1: An automatic classification tool for PVS1 interpretation of null variants , 2019, bioRxiv.

[9]  John P. Rice,et al.  Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.

[10]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[11]  Meng Wang,et al.  AutismKB 2.0: a knowledgebase for the genetic evidence of autism spectrum disorder , 2018, Database J. Biol. Databases Curation.

[12]  Marina T. DiStefano,et al.  Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion , 2018, Human mutation.

[13]  H. Van Esch,et al.  Interstitial microdeletion of 17q11.2 is associated with hypotonia, fatigue, intellectual disability, and a subtle facial phenotype in three unrelated patients , 2018, American journal of medical genetics. Part A.

[14]  S. Scherer,et al.  Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach , 2017, Dialogues in clinical neuroscience.

[15]  I. Piras,et al.  Copy number variation in 19 Italian multiplex families with autism spectrum disorder: Importance of synaptic and neurite elongation genes , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  I. Piras,et al.  Recurrent 15q11.2 BP1‐BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders , 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[17]  Daniele Merico,et al.  Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. , 2015, JAMA.

[18]  Giorgia Pellanda,et al.  High prevalence of pathologic copy number variants detected by chromosomal microarray in Swiss-Italian children with autism spectrum disorders. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[19]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[20]  Kathryn Roeder,et al.  Most genetic risk for autism resides with common variation , 2014, Nature Genetics.

[21]  Lucas Cheadle,et al.  Activity-Dependent Regulation of Dendritic Complexity by Semaphorin 3A through Farp1 , 2014, The Journal of Neuroscience.

[22]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[23]  J. Glennon,et al.  Using genetic findings in autism for the development of new pharmaceutical compounds , 2013, Psychopharmacology.

[24]  K. Friend,et al.  Cognitive deficit and autism spectrum disorders: prospective diagnosis by array CGH , 2014, Pathology.

[25]  A. Battaglia,et al.  Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[26]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[27]  G. B. Schaefer,et al.  Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions , 2013, Genetics in Medicine.

[28]  E. Pivnick,et al.  The Interstitial Duplication 15q11.2-q13 Syndrome Includes Autism, Mild Facial Anomalies and a Characteristic EEG Signature , 2013, Autism research : official journal of the International Society for Autism Research.

[29]  Bernie Devlin,et al.  Genetic architecture in autism spectrum disorder. , 2012, Current opinion in genetics & development.

[30]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[31]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[32]  J. Rosenfeld,et al.  Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders , 2010, Genetics in Medicine.

[33]  Margaret A. Pericak-Vance,et al.  A genome-wide scan for common alleles affecting risk for autism , 2010, Human molecular genetics.

[34]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[35]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[36]  Sharyn A. Lincoln,et al.  Clinical Genetic Testing for Patients With Autism Spectrum Disorders , 2010, Pediatrics.

[37]  P. Stankiewicz,et al.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.

[38]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[39]  Robert T. Schultz,et al.  Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.

[40]  Tomi D. Berney,et al.  High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L–DOCK4 gene region in autism susceptibility , 2009, Molecular Psychiatry.

[41]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[42]  Thomas Bourgeron,et al.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.

[43]  D. Geschwind,et al.  Autism spectrum disorders: developmental disconnection syndromes , 2007, Current Opinion in Neurobiology.

[44]  M. Owen,et al.  Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Francks,et al.  A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium. , 1998, Human molecular genetics.

[47]  J. Carlson,et al.  The Factorial Structure of the Raven Coloured Progressive Matrices Test , 1976 .